PMDI · Psychemedics Corp · Insider Trading

Mr. Lindsay is the Managing Member of Powell Anderson Capital Partners LLC, which serves as the Investment Manager of Powell Anderson Capital LP, and the Managing Member of PACP Jupiter LLC (collectively, the "Funds"). The Funds acquired the shares as specified in Table I (collectively, the Funds acquired (159,700) shares and collectively own (984,256) shares following the transactions). As Investment Manager and Managing Member of the Funds, Powell Anderson Capital Partners LLC, and Mr. Lindsay as Managing Member of Powell Anderson Capital Partners LLC, each possess the power to vote and dispose or direct the disposition of the shares acquired by the Funds.

These shares are held by Powell Anderson Capital LP.

Mr. Lindsay is the Managing Member of Powell Anderson Capital Partners LLC, which serves as the Investment Manager of Powell Anderson Capital LP, and the Managing Member of PACP Jupiter LLC (collectively, the "Funds"). The Funds acquired the shares as specified in Table I (collectively, the Funds acquired (159,700) shares and collectively own (984,256) shares following the transactions). As Investment Manager and Managing Member of the Funds, Powell Anderson Capital Partners LLC, and Mr. Lindsay as Managing Member of Powell Anderson Capital Partners LLC, each possess the power to vote and dispose or direct the disposition of the shares acquired by the Funds.

These shares are held by PACP Jupiter LLC.

Mr. Lindsay is the Managing Member of Powell Anderson Capital Partners LLC, which serves as the Investment Manager of Powell Anderson Capital LP, and the Managing Member of PACP Jupiter LLC (collectively, the "Funds"). The Funds acquired the shares as specified in Table I (collectively, the Funds acquired (159,700) shares and collectively own (984,256) shares following the transactions). As Investment Manager and Managing Member of the Funds, Powell Anderson Capital Partners LLC, and Mr. Lindsay as Managing Member of Powell Anderson Capital Partners LLC, each possess the power to vote and dispose or direct the disposition of the shares acquired by the Funds.

These shares are held by PACP Jupiter LLC.

Mr. Lindsay is the Managing Member of Powell Anderson Capital Partners LLC, which serves as the Investment Manager of Powell Anderson Capital LP, and the Managing Member of PACP Jupiter LLC (collectively, the "Funds"). The Funds acquired the shares as specified in Table I (collectively, the Funds acquired (159,700) shares and collectively own (984,256) shares following the transactions). As Investment Manager and Managing Member of the Funds, Powell Anderson Capital Partners LLC, and Mr. Lindsay as Managing Member of Powell Anderson Capital Partners LLC, each possess the power to vote and dispose or direct the disposition of the shares acquired by the Funds.

These shares are held by Powell Anderson Capital LP.

Mr. Lindsay is the Managing Member of Powell Anderson Capital Partners LLC, which serves as the Investment Manager of Powell Anderson Capital LP, and the Managing Member of PACP Jupiter LLC (collectively, the "Funds"). The Funds acquired the shares as specified in Table I (collectively, the Funds acquired (159,700) shares and collectively own (984,256) shares following the transactions). As Investment Manager and Managing Member of the Funds, Powell Anderson Capital Partners LLC, and Mr. Lindsay as Managing Member of Powell Anderson Capital Partners LLC, each possess the power to vote and dispose or direct the disposition of the shares acquired by the Funds.

These shares are held by PACP Jupiter LLC.

Mr. Lindsay is the Managing Member of Powell Anderson Capital Partners LLC, which serves as the Investment Manager of Powell Anderson Capital LP, and the Managing Member of PACP Jupiter LLC (collectively, the "Funds"). The Funds acquired the shares as specified in Table I (collectively, the Funds acquired (86,991) shares and collectively own (824,556) shares following the transactions). As Investment Manager and Managing Member of the Funds, Powell Anderson Capital Partners LLC, and Mr. Lindsay as Managing Member of Powell Anderson Capital Partners LLC, each possess the power to vote and dispose or direct the disposition of the shares acquired by the Funds.

These shares are held by PACP Jupiter LLC.

Mr. Lindsay is the Managing Member of Powell Anderson Capital Partners LLC, which serves as the Investment Manager of Powell Anderson Capital LP, and the Managing Member of PACP Jupiter LLC (collectively, the "Funds"). The Funds acquired the shares as specified in Table I (collectively, the Funds acquired (86,991) shares and collectively own (824,556) shares following the transactions). As Investment Manager and Managing Member of the Funds, Powell Anderson Capital Partners LLC, and Mr. Lindsay as Managing Member of Powell Anderson Capital Partners LLC, each possess the power to vote and dispose or direct the disposition of the shares acquired by the Funds.

These shares are held by PACP Jupiter LLC.

Represents shares of common stock, par value $0.005 per share, held by 3K Limited Partnership ("3K Limited"), of which the reporting person is the general partner (the "Reporting Person"), and repurchased by the Issuer, pursuant to a stock repurchase agreement, dated as of December 10, 2024, by and among the Issuer and 3K Limited, following the final determination of the purchase price required to purchase fractional shares in the Issuer's recently completed reverse stock split.

The Reporting Person holds 218,728 shares indirectly by the Peter H. Kamin Revocable Trust dated February 2003, 146,998 shares indirectly by the Peter H. Kamin Childrens Trust dated March 1997 and 1,133,984 shares indirectly by 3K Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes.

Mr. Lindsay is the Managing Member of Powell Anderson Capital Partners LLC, which serves as the Investment Manager of Powell Anderson Capital LP, and the Managing Member of PACP Jupiter LLC (collectively, the "Funds"). The Funds acquired the shares as specified in Table I (collectively, the Funds acquired (86,991) shares and collectively own (824,556) shares following the transactions). As Investment Manager and Managing Member of the Funds, Powell Anderson Capital Partners LLC, and Mr. Lindsay as Managing Member of Powell Anderson Capital Partners LLC, each possess the power to vote and dispose or direct the disposition of the shares acquired by the Funds.

These shares are held by PACP Jupiter LLC.

Represents shares of common stock, par value $0.005 per share, of the Issuer issued and sold to 3K Limited Partnership ("3K Limited"), of which the reporting person is the general partner (the "Reporting Person"), pursuant to a stock purchase agreement, dated as of August 12, 2024, by and among the Issuer, 3K Limited, the Reporting person, in his individual capacity, the Peter H. Kamin Revocable Trust dated February 2003 (the "Kamin Trust"), the Peter H. Kamin Childrens Trust dated March 1997 (the "Kamin Childrens Trust"), the Peter H. Kamin GST Trust and the Peter H. Kamin Family Foundation, of which the Reporting Person is sole trustee.

The Reporting Person holds 218,728 shares indirectly by the Kamin Trust, 146,998 shares indirectly by the Kamin Childrens Trust and 1,454,692 shares indirectly by 3K Limited Partnership. The Reporting Person disclaims beneficial ownership of these Securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes.

The option becomes exercisable with respect to 50% of the shares on January 22, 2025 and with respect to the remaining 50% on January 22, 2026.

The option becomes exercisable, if at all, in two 35,000 share increments. The first increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2027 shall have exceeded $5.50. The second increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2028 shall have exceeded $6.50.

The option becomes exercisable, if at all, in two 40,000 share increments. The first increment of 40,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before September 21, 2026 shall have exceeded $5.50. The second increment of 40,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before September 21, 2027 shall have exceeded $6.50.

The option becomes exercisable with respect to 50% of the shares on September 18, 2024 and with respect to the remaining 50% on September 18, 2025.

The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.88, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on the earlier of: (i) August 17, 2024 or (ii) one business day prior to the date of the 2024 Annual Meeting of Stockholders.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 25% of the shares on the first anniversary date of the grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on the earlier of: (i) August 17, 2024 or (ii) one business day prior to the date of the 2024 Annual Meeting of Stockholders.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on the earlier of: (i) August 17, 2024 or (ii) one business day prior to the date of the 2024 Annual Meeting of Stockholders.

The reporting person also holds 218,728 shares indirectly by the Peter H. Kamin Revocable Trust dated February 2003, 146,998 shares indirectly by the Peter H. Kamin Childrens Trust dated March 1997, and 44,980 shares indirectly by 3K Limited Partnership. The reporting person disclaims beneficial ownership of these Securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purposes.

The reporting person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on the earlier of: (i) August 17, 2024 or (ii) one business day prior to the date of the 2024 Annual Meeting of Stockholders.

The reporting person also holds 25,181 shares indirectly by G3 Investment Holdings LLC. The reporting person, as a member of G3 Investment Holdings LLC, may be deemed to beneficially own the securities directly owned by G3 Investment Holdings LLC.

The option becomes exercisable, if at all, in two 100,000 share increments if the weighted average daily price of Psychemedics Corporation's common stock on the Nasdaq Stock Market during any 60 consecutive calendar day period exceeds $5.50 and $6.50, respectively.

The option becomes exercisable with respect to 50% of the shares on August 17, 2024 and with respect to the remaining 50% on August 17, 2025.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2022 that vested on May 22, 2023.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2022 that vested on May 22, 2023.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2022 that vested on May 22, 2023.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2021 that vested on May 15, 2023.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2021 that vested on May 15, 2023.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2021 that vested on May 15, 2023.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2020 that vested on November 11, 2022.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2020 that vested on November 11, 2022.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2020 that vested on November 11, 2022.

The reporting person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on August 12, 2023 and with respect to the remaining 50% on August 12, 2024, so long as the recipient continues as a director of the Issuer through each such respective vesting date.

The reporting person also holds 25,181 shares indirectly by G3 Investment Holdings LLC. The reporting person, as a member of G3 Investment Holdings LLC, may be deemed to beneficially own the securities directly owned by G3 Investment Holdings LLC.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on August 12, 2023 and with respect to the remaining 50% on August 12, 2024, so long as the recipient continues as a director of the Issuer through each such respective vesting date.

The reporting person also holds 218,728 shares indirectly by the Peter H. Kamin Revocable Trust dated February 2003, 146,998 shares indirectly by the Peter H. Kamin Childrens Trust dated March 1997, and 44,980 shares indirectly by 3K Limited Partnership. The reporting person disclaims beneficial ownership of these Securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purposes.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on April 30, 2023 and with respect to the remaining 50% on April 30, 2024, so long as the recipient continues as a director of the Issuer through each such respective vesting date.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on April 30, 2023 and with respect to the remaining 50% on April 30, 2024, so long as the recipient continues as a director of the Issuer through each such respective vesting date.

The reporting person also holds 111,381 shares indirectly by Trust and 1,600 shares by Spouse.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on April 30, 2023 and with respect to the remaining 50% on April 30, 2024, so long as the recipient continues as a director of the Issuer through each such respective vesting date.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 25% of the shares on the first anniversay date of the grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date,

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 25% of the shares on the first anniversay date of the grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date,

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 25% of the shares on the first anniversay date of the grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date,

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on April 30, 2023 and with respect to the remaining 50% on April 30, 2024, so long as the recipient continues as a director of the Issuer through each such respective vesting date.

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 25% of the shares on the first anniversay date of the grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date,

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2021 that vested on May 13, 2022.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2021 that vested on May 13, 2022.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2021 that vested on May 13, 2022.

Represents shares withheld to cover tax liability with respect to stock unit awards granted in 2021 that vested on May 13, 2022.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.57 to $6.80 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

These securities are owned by the Peter H. Kamin Revocable Trust dated February 2003. The Reporting Person is the Trustee of the Trust. The Reporting Person disclaims beneficial ownership of these Securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.57 to $6.80 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

These securities are owned by 3K limited Partnership. The Reporting Person is the General Partner of the Partnership. The Reporting Person disclaims beneficial ownership of these Securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such Securities for section 16 or any other purposes.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.57 to $6.80 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.57 to $6.80 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

These securities are owned by the Peter H. Kamin Childrens Trust dated March 1997. The Reporting Person is the Trustee of the Trust. The Reporting Person disclaims beneficial ownership of these Securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes.